SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001753926-22-000541
Filing Date
2022-04-18
Accepted
2022-04-18 16:13:47
Documents
2
Group Members
ELIYAHU HASSETT

Document Format Files

Seq Description Document Type Size
1 SC 13D/A g082973_13d.htm SC 13D/A 47203
2 EXHIBIT 99.1 g082973_ex99-1.htm EX-99.1 33722
  Complete submission text file 0001753926-22-000541.txt   82801
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Subject) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87050 | Film No.: 22832292
SIC: 2834 Pharmaceutical Preparations

Mailing Address PALM GROVE HOUSE, P.O. BOX 438 ROAD TOWN, TORTOLLA D8 VG1110
Business Address PALM GROVE HOUSE, P.O. BOX 438 ROAD TOWN, TORTOLLA D8 VG1110 3 505-600-4050
Lorient Ventures Ltd (Filed by) CIK: 0001827787 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D/A